Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Kreuter, A; Pantelaki, I; Michalowitz, AL; Wieland, U; Cerroni, L; Oellig, F; Tigges, C.
CD30-positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia.
Clin Exp Dermatol. 2018; 43(5):585-588 (- Case Report)
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Cerroni Lorenzo

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

CD30-positive primary cutaneous anaplastic large cell lymphoma (C-ALCL) is an indolent type of cutaneous lymphoma with favourable clinical prognosis. Pseudocarcinomatous hyperplasia (PCH) is a rare benign epithelial condition that can resemble invasive squamous cell carcinoma both clinically and histopathologically. PCH predominantly occurs in CD30-positive lymphoproliferative disorders. We report a 75-year-old woman with PCH in a multifocal C-ALCL located on the scalp and right retroauricular area, which rapidly responded to treatment with psoralen ultraviolet A photochemotherapy. Comprehensive virological analyses for potential oncogenic viruses, including Epstein-Barr virus, human herpesvirus-8, human papillomaviruses, the recently discovered cutavirus and nine different human polyomaviruses, were negative. © 2018 British Association of Dermatologists.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Female -
Head and Neck Neoplasms - complications
Head and Neck Neoplasms - drug therapy
Head and Neck Neoplasms - metabolism
Humans -
Hyperplasia - complications
Hyperplasia - drug therapy
Hyperplasia - pathology
Ki-1 Antigen - metabolism
Lymphoma, Primary Cutaneous Anaplastic Large Cell - complications
Lymphoma, Primary Cutaneous Anaplastic Large Cell - drug therapy
Lymphoma, Primary Cutaneous Anaplastic Large Cell - metabolism
PUVA Therapy -
Scalp -
Skin - pathology
Skin Neoplasms - complications
Skin Neoplasms - drug therapy
Skin Neoplasms - metabolism

© Med Uni Graz Impressum